vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and Revolve Group, Inc. (RVLV). Click either name above to swap in a different company.
Revolve Group, Inc. is the larger business by last-quarter revenue ($324.4M vs $207.8M, roughly 1.6× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 5.7%, a 51.7% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $-13.3M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Revolve Theatre Company is a Henley-on-Thames based theatre company specialising in political and Shakespearean plays. The company is owned by Oliver Dench, Joe Morris and Tom Smith.
IDYA vs RVLV — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $324.4M |
| Net Profit | $119.2M | $18.6M |
| Gross Margin | — | 53.3% |
| Operating Margin | 52.2% | 6.3% |
| Net Margin | 57.4% | 5.7% |
| Revenue YoY | — | 10.4% |
| Net Profit YoY | 330.1% | 50.4% |
| EPS (diluted) | $1.33 | $0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $324.4M | ||
| Q3 25 | $207.8M | $295.6M | ||
| Q2 25 | — | $309.0M | ||
| Q1 25 | — | $296.7M | ||
| Q4 24 | — | $293.7M | ||
| Q3 24 | $0 | $283.1M | ||
| Q2 24 | $0 | $282.5M | ||
| Q1 24 | $0 | $270.6M |
| Q4 25 | — | $18.6M | ||
| Q3 25 | $119.2M | $21.2M | ||
| Q2 25 | — | $10.2M | ||
| Q1 25 | — | $11.8M | ||
| Q4 24 | — | $12.3M | ||
| Q3 24 | $-51.8M | $11.0M | ||
| Q2 24 | $-52.8M | $15.4M | ||
| Q1 24 | $-39.6M | $10.9M |
| Q4 25 | — | 53.3% | ||
| Q3 25 | — | 54.6% | ||
| Q2 25 | — | 54.1% | ||
| Q1 25 | — | 52.0% | ||
| Q4 24 | — | 52.5% | ||
| Q3 24 | — | 51.2% | ||
| Q2 24 | — | 54.0% | ||
| Q1 24 | — | 52.3% |
| Q4 25 | — | 6.3% | ||
| Q3 25 | 52.2% | 7.1% | ||
| Q2 25 | — | 5.8% | ||
| Q1 25 | — | 5.0% | ||
| Q4 24 | — | 3.9% | ||
| Q3 24 | — | 5.0% | ||
| Q2 24 | — | 5.8% | ||
| Q1 24 | — | 3.4% |
| Q4 25 | — | 5.7% | ||
| Q3 25 | 57.4% | 7.2% | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 4.0% | ||
| Q4 24 | — | 4.2% | ||
| Q3 24 | — | 3.9% | ||
| Q2 24 | — | 5.4% | ||
| Q1 24 | — | 4.0% |
| Q4 25 | — | $0.27 | ||
| Q3 25 | $1.33 | $0.29 | ||
| Q2 25 | — | $0.14 | ||
| Q1 25 | — | $0.16 | ||
| Q4 24 | — | $0.18 | ||
| Q3 24 | $-0.60 | $0.15 | ||
| Q2 24 | $-0.68 | $0.21 | ||
| Q1 24 | $-0.53 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $292.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $512.5M |
| Total Assets | $1.2B | $765.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $292.3M | ||
| Q3 25 | $786.9M | $315.4M | ||
| Q2 25 | — | $310.7M | ||
| Q1 25 | — | $300.8M | ||
| Q4 24 | — | $256.6M | ||
| Q3 24 | $920.0M | $252.8M | ||
| Q2 24 | $701.7M | $244.7M | ||
| Q1 24 | $698.8M | $273.4M |
| Q4 25 | — | $512.5M | ||
| Q3 25 | $1.1B | $490.2M | ||
| Q2 25 | — | $468.6M | ||
| Q1 25 | — | $453.4M | ||
| Q4 24 | — | $437.8M | ||
| Q3 24 | $1.2B | $420.8M | ||
| Q2 24 | $931.7M | $405.8M | ||
| Q1 24 | $935.3M | $389.9M |
| Q4 25 | — | $765.0M | ||
| Q3 25 | $1.2B | $751.3M | ||
| Q2 25 | — | $722.9M | ||
| Q1 25 | — | $713.9M | ||
| Q4 24 | — | $665.5M | ||
| Q3 24 | $1.2B | $670.9M | ||
| Q2 24 | $973.7M | $657.8M | ||
| Q1 24 | $961.5M | $650.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $-10.2M |
| Free Cash FlowOCF − Capex | $142.2M | $-13.3M |
| FCF MarginFCF / Revenue | 68.4% | -4.1% |
| Capex IntensityCapex / Revenue | 0.0% | 1.0% |
| Cash ConversionOCF / Net Profit | 1.19× | -0.55× |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $48.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-10.2M | ||
| Q3 25 | $142.2M | $11.8M | ||
| Q2 25 | — | $12.6M | ||
| Q1 25 | — | $45.1M | ||
| Q4 24 | — | $3.9M | ||
| Q3 24 | $-49.2M | $9.1M | ||
| Q2 24 | $-32.9M | $-24.7M | ||
| Q1 24 | $-43.8M | $38.4M |
| Q4 25 | — | $-13.3M | ||
| Q3 25 | $142.2M | $7.5M | ||
| Q2 25 | — | $10.4M | ||
| Q1 25 | — | $43.4M | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | $-49.7M | $8.0M | ||
| Q2 24 | $-33.9M | $-25.7M | ||
| Q1 24 | $-45.1M | $36.7M |
| Q4 25 | — | -4.1% | ||
| Q3 25 | 68.4% | 2.5% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | 14.6% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | — | -9.1% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | — | 1.0% | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | -0.55× | ||
| Q3 25 | 1.19× | 0.56× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 3.82× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | -1.60× | ||
| Q1 24 | — | 3.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDYA
Segment breakdown not available.
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
